ID

8596

Descrizione

Eligibility Form for Protocol #040 - PR4001 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=CCE1F242-913A-4391-E034-0003BA12F5E7

collegamento

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=CCE1F242-913A-4391-E034-0003BA12F5E7

Keywords

versioni (3)
  1. 19/09/12 19/09/12 -
  2. 09/01/15 09/01/15 - Martin Dugas
  3. 09/01/15 09/01/15 - Martin Dugas
Caricato su

9 gennaio 2015

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0 Legacy
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Sarcoma, Kaposi xxx Eligibility - Eligibility Form for Protocol #040 - PR4001 - 2266387v3.0

Inglese

No Instruction available.

1 moduli  
  1. StudyEvent: Eligibility Form for Protocol #040 - PR4001
    1. No Instruction available.
Ccrr Module For Eligibility Form For Protocol #040 - Pr4001
Descrizione

Ccrr Module For Eligibility Form For Protocol #040 - Pr4001

Patient Initials
Descrizione

Patient Initials

Tipo di dati

text

Alias
NCI Thesaurus ValueDomain
C25191
UMLS CUI-1
C2986440
NCI Thesaurus ObjectClass
C16960
NCI Thesaurus Property
C25536
Study#
Descrizione

Protocol ID Coordinating Group

Tipo di dati

text

Alias
NCI Thesaurus ValueDomain
C25337
UMLS CUI-1
C3274381
NCI Thesaurus ObjectClass
C25320
UMLS CUI-2
C1711341
NCI Thesaurus Property
C25462
NCI Thesaurus Property-2
C25364
Site#
Descrizione

NCIInstitutionIdentifierCode

Tipo di dati

text

Alias
NCI Thesaurus ValueDomain
C25162
UMLS 2011AA ValueDomain
C0805701
NCI Thesaurus ObjectClass
C21541
UMLS 2011AA ObjectClass
C0018704
NCI Thesaurus Property
C25364
UMLS 2011AA Property
C0600091
NCI Thesaurus ObjectClass-2
C19202
UMLS 2011AA ObjectClass-2
C1513882
ID#
Descrizione

Patient Study ID

Tipo di dati

text

Alias
NCI Thesaurus ValueDomain
C25337
UMLS CUI-1
C2348585
NCI Thesaurus ObjectClass
C16960
NCI Thesaurus Property
C25462
NCI Thesaurus Property-2
C25364
Visit Date
Descrizione

Dateofassessment

Tipo di dati

text

Does the patient have biopsy proven KS involving the skin, lymph nodes, oral cavity, gastrointestinal (GI) tract and/or lungs?
Descrizione

DoesthepatienthavebiopsyprovenKSinvolvingtheskin,lymphnodes,oralcavity,gastrointestinal(GI)tractand/orlungs?

Tipo di dati

boolean

Does the patient have Serologic documentation of HIV infection 21 days prior to study entry, as evidenced by positive ELISA, positive Western Blot, or other federally approved licensed HIV test?
Descrizione

DoesthepatienthaveSerologicdocumentationofHIVinfection21dayspriortostudyentry,asevidencedbypositiveELISA,positiveWesternBlot,orotherfederallyapprovedlicensedHIVtest?

Tipo di dati

boolean

Is patient's baseline Karnofsky performance status >60%?
Descrizione

Ispatient'sbaselineKarnofskyperformancestatus>60%?

Tipo di dati

boolean

Is patient's hemoglobin > 8 g/dl within 7 days of study entry?
Descrizione

Ispatient'shemoglobin>8g/dlwithin7daysofstudyentry?

Tipo di dati

boolean

Is patient's absolute neutrophil count > 1500 cells/mm3 and platelets > 100,000 cells/mm3 within 7 days of study entry?
Descrizione

Ispatient'sabsoluteneutrophilcount>1500cells/mm3andplatelets>100,000cells/mm3within7daysofstudyentry?

Tipo di dati

boolean

Is patient's creatinine < 1.5 times the upper limit of normal within 7 days of study entry?
Descrizione

Ispatient'screatinine<1.5timestheupperlimitofnormalwithin7daysofstudyentry?

Tipo di dati

boolean

Is patient's total bilirubin <1.5x ULN within 7 days of study entry?
Descrizione

Ispatient'stotalbilirubin<1.5xULNwithin7daysofstudyentry?

Tipo di dati

boolean

Is patient's AST (SGOT) and ALT (SGPT) < 3 x the upper limit of normal within 7 days of study entry?
Descrizione

Ispatient'sAST(SGOT)andALT(SGPT)<3xtheupperlimitofnormalwithin7daysofstudyentry?

Tipo di dati

boolean

Is patient's life expectancy > 3 months?
Descrizione

Ispatient'slifeexpectancy>3months?

Tipo di dati

boolean

Is the patient age of 18 or older?
Descrizione

Isthepatientageof18orolder?

Tipo di dati

boolean

Does the patient have ability and willingness to give informed consent?
Descrizione

Doesthepatienthaveabilityandwillingnesstogiveinformedconsent?

Tipo di dati

boolean

If female capable of childbearing, has the patient had a negative serum B-HCG within 72 hours prior to study entry?
Descrizione

Iffemalecapableofchildbearing,hasthepatienthadanegativeserumB-HCGwithin72hourspriortostudyentry?

Tipo di dati

text

If female capable of childbearing, does the patient agree to practice adequate birth control to prevent pregnancy while receiving treatment and for three months after treatment is discontinued?
Descrizione

Iffemalecapableofchildbearing,doesthepatientagreetopracticeadequatebirthcontroltopreventpregnancywhilereceivingtreatmentandforthreemonthsaftertreatmentisdiscontinued?

Tipo di dati

text

If female, is the patient breast feeding?
Descrizione

Iffemale,isthepatientbreastfeeding?

Tipo di dati

text

If male of child fathering potential, does the patient agree to practice adequate birth control?
Descrizione

Ifmaleofchildfatheringpotential,doesthepatientagreetopracticeadequatebirthcontrol?

Tipo di dati

text

In the opinion of the investigator, is the patient capable of complying with the protocol?
Descrizione

Intheopinionoftheinvestigator,isthepatientcapableofcomplyingwiththeprotocol?

Tipo di dati

boolean

If patient is receiving antiretroviral therapy, is the patient on a stable regimen for at least 4 weeks prior to study entry?
Descrizione

Ifpatientisreceivingantiretroviraltherapy,isthepatientonastableregimenforatleast4weekspriortostudyentry?

Tipo di dati

boolean

Does the patient have concurrent, acute, active opportunistic infection other than oral thrush or genital herpes within 14 days of enrollment?
Descrizione

Doesthepatienthaveconcurrent,acute,activeopportunisticinfectionotherthanoralthrushorgenitalherpeswithin14daysofenrollment?

Tipo di dati

boolean

Does the patient have symptomatic visceral Kaposi's Sarcoma requiring cytotoxic therapy unless the patient has already been shown to be refractory to or intolerant of all currently approved agents for visceral Kaposi's Sarcoma?
Descrizione

DoesthepatienthavesymptomaticvisceralKaposi'sSarcomarequiringcytotoxictherapyunlessthepatienthasalreadybeenshowntoberefractorytoorintolerantofallcurrentlyapprovedagentsforvisceralKaposi'sSarcoma?

Tipo di dati

boolean

Does the patient have concurrent neoplasia requiring cytotoxic therapy?
Descrizione

Doesthepatienthaveconcurrentneoplasiarequiringcytotoxictherapy?

Tipo di dati

boolean

Has the patient had acute treatment for an infection (other than oral thrush or genital herpes) or other serious medical illness within 14 days of study entry?
Descrizione

Hasthepatienthadacutetreatmentforaninfection(otherthanoralthrushorgenitalherpes)orotherseriousmedicalillnesswithin14daysofstudyentry?

Tipo di dati

boolean

Has the patient had anti-neoplastic treatment for Kaposi's Sarcoma (including chemotherapy, radiation therapy, local therapy, biological therapy, or investigational therapy) within two weeks of study entry?
Descrizione

Hasthepatienthadanti-neoplastictreatmentforKaposi'sSarcoma(includingchemotherapy,radiationtherapy,localtherapy,biologicaltherapy,orinvestigationaltherapy)withintwoweeksofstudyentry?

Tipo di dati

boolean

Has the patient had previous local therapy of any KS-indicator lesion within 60 days unless the lesion has clearly progressed since treatment?
Descrizione

HasthepatienthadpreviouslocaltherapyofanyKS-indicatorlesionwithin60daysunlessthelesionhasclearlyprogressedsincetreatment?

Tipo di dati

boolean

Has the patient used of investigational drugs other than IND-available anti-retroviral agents?
Descrizione

HasthepatientusedofinvestigationaldrugsotherthanIND-availableanti-retroviralagents?

Tipo di dati

boolean

Does the patient have evidence of a prior MI or cardiac ischemia?
Descrizione

DoesthepatienthaveevidenceofapriorMIorcardiacischemia?

Tipo di dati

boolean

Ritorna all'inizio della pagina

Similar models

No Instruction available.

1 moduli
  1. StudyEvent: Eligibility Form for Protocol #040 - PR4001
    1. No Instruction available.
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Ccrr Module For Eligibility Form For Protocol #040 - Pr4001
Patient Initials
Item
Patient Initials
text
C25191 (NCI Thesaurus ValueDomain)
C2986440 (UMLS CUI-1)
C16960 (NCI Thesaurus ObjectClass)
C25536 (NCI Thesaurus Property)
Protocol ID Coordinating Group
Item
Study#
text
C25337 (NCI Thesaurus ValueDomain)
C3274381 (UMLS CUI-1)
C25320 (NCI Thesaurus ObjectClass)
C1711341 (UMLS CUI-2)
C25462 (NCI Thesaurus Property)
C25364 (NCI Thesaurus Property-2)
NCIInstitutionIdentifierCode
Item
Site#
text
C25162 (NCI Thesaurus ValueDomain)
C0805701 (UMLS 2011AA ValueDomain)
C21541 (NCI Thesaurus ObjectClass)
C0018704 (UMLS 2011AA ObjectClass)
C25364 (NCI Thesaurus Property)
C0600091 (UMLS 2011AA Property)
C19202 (NCI Thesaurus ObjectClass-2)
C1513882 (UMLS 2011AA ObjectClass-2)
Patient Study ID
Item
ID#
text
C25337 (NCI Thesaurus ValueDomain)
C2348585 (UMLS CUI-1)
C16960 (NCI Thesaurus ObjectClass)
C25462 (NCI Thesaurus Property)
C25364 (NCI Thesaurus Property-2)
Dateofassessment
Item
Visit Date
text
DoesthepatienthavebiopsyprovenKSinvolvingtheskin,lymphnodes,oralcavity,gastrointestinal(GI)tractand/orlungs?
Item
Does the patient have biopsy proven KS involving the skin, lymph nodes, oral cavity, gastrointestinal (GI) tract and/or lungs?
boolean
DoesthepatienthaveSerologicdocumentationofHIVinfection21dayspriortostudyentry,asevidencedbypositiveELISA,positiveWesternBlot,orotherfederallyapprovedlicensedHIVtest?
Item
Does the patient have Serologic documentation of HIV infection 21 days prior to study entry, as evidenced by positive ELISA, positive Western Blot, or other federally approved licensed HIV test?
boolean
Ispatient'sbaselineKarnofskyperformancestatus>60%?
Item
Is patient's baseline Karnofsky performance status >60%?
boolean
Ispatient'shemoglobin>8g/dlwithin7daysofstudyentry?
Item
Is patient's hemoglobin > 8 g/dl within 7 days of study entry?
boolean
Ispatient'sabsoluteneutrophilcount>1500cells/mm3andplatelets>100,000cells/mm3within7daysofstudyentry?
Item
Is patient's absolute neutrophil count > 1500 cells/mm3 and platelets > 100,000 cells/mm3 within 7 days of study entry?
boolean
Ispatient'screatinine<1.5timestheupperlimitofnormalwithin7daysofstudyentry?
Item
Is patient's creatinine < 1.5 times the upper limit of normal within 7 days of study entry?
boolean
Ispatient'stotalbilirubin<1.5xULNwithin7daysofstudyentry?
Item
Is patient's total bilirubin <1.5x ULN within 7 days of study entry?
boolean
Ispatient'sAST(SGOT)andALT(SGPT)<3xtheupperlimitofnormalwithin7daysofstudyentry?
Item
Is patient's AST (SGOT) and ALT (SGPT) < 3 x the upper limit of normal within 7 days of study entry?
boolean
Ispatient'slifeexpectancy>3months?
Item
Is patient's life expectancy > 3 months?
boolean
Isthepatientageof18orolder?
Item
Is the patient age of 18 or older?
boolean
Doesthepatienthaveabilityandwillingnesstogiveinformedconsent?
Item
Does the patient have ability and willingness to give informed consent?
boolean
Item
If female capable of childbearing, has the patient had a negative serum B-HCG within 72 hours prior to study entry?
text
CL.12
Code List
If female capable of childbearing, has the patient had a negative serum B-HCG within 72 hours prior to study entry?
CL Item
Yes (Yes)
CL Item
No (No)
CL Item
N/A (N/A)
Item
If female capable of childbearing, does the patient agree to practice adequate birth control to prevent pregnancy while receiving treatment and for three months after treatment is discontinued?
text
CL.13
Code List
If female capable of childbearing, does the patient agree to practice adequate birth control to prevent pregnancy while receiving treatment and for three months after treatment is discontinued?
CL Item
Yes (Yes)
CL Item
No (No)
CL Item
N/A (N/A)
Item
If female, is the patient breast feeding?
text
CL.14
Code List
If female, is the patient breast feeding?
CL Item
Yes (Yes)
CL Item
No (No)
CL Item
N/A (N/A)
Item
If male of child fathering potential, does the patient agree to practice adequate birth control?
text
CL.15
Code List
If male of child fathering potential, does the patient agree to practice adequate birth control?
CL Item
Yes (Yes)
CL Item
No (No)
CL Item
N/A (N/A)
Intheopinionoftheinvestigator,isthepatientcapableofcomplyingwiththeprotocol?
Item
In the opinion of the investigator, is the patient capable of complying with the protocol?
boolean
Ifpatientisreceivingantiretroviraltherapy,isthepatientonastableregimenforatleast4weekspriortostudyentry?
Item
If patient is receiving antiretroviral therapy, is the patient on a stable regimen for at least 4 weeks prior to study entry?
boolean
Doesthepatienthaveconcurrent,acute,activeopportunisticinfectionotherthanoralthrushorgenitalherpeswithin14daysofenrollment?
Item
Does the patient have concurrent, acute, active opportunistic infection other than oral thrush or genital herpes within 14 days of enrollment?
boolean
DoesthepatienthavesymptomaticvisceralKaposi'sSarcomarequiringcytotoxictherapyunlessthepatienthasalreadybeenshowntoberefractorytoorintolerantofallcurrentlyapprovedagentsforvisceralKaposi'sSarcoma?
Item
Does the patient have symptomatic visceral Kaposi's Sarcoma requiring cytotoxic therapy unless the patient has already been shown to be refractory to or intolerant of all currently approved agents for visceral Kaposi's Sarcoma?
boolean
Doesthepatienthaveconcurrentneoplasiarequiringcytotoxictherapy?
Item
Does the patient have concurrent neoplasia requiring cytotoxic therapy?
boolean
Hasthepatienthadacutetreatmentforaninfection(otherthanoralthrushorgenitalherpes)orotherseriousmedicalillnesswithin14daysofstudyentry?
Item
Has the patient had acute treatment for an infection (other than oral thrush or genital herpes) or other serious medical illness within 14 days of study entry?
boolean
Hasthepatienthadanti-neoplastictreatmentforKaposi'sSarcoma(includingchemotherapy,radiationtherapy,localtherapy,biologicaltherapy,orinvestigationaltherapy)withintwoweeksofstudyentry?
Item
Has the patient had anti-neoplastic treatment for Kaposi's Sarcoma (including chemotherapy, radiation therapy, local therapy, biological therapy, or investigational therapy) within two weeks of study entry?
boolean
HasthepatienthadpreviouslocaltherapyofanyKS-indicatorlesionwithin60daysunlessthelesionhasclearlyprogressedsincetreatment?
Item
Has the patient had previous local therapy of any KS-indicator lesion within 60 days unless the lesion has clearly progressed since treatment?
boolean
HasthepatientusedofinvestigationaldrugsotherthanIND-availableanti-retroviralagents?
Item
Has the patient used of investigational drugs other than IND-available anti-retroviral agents?
boolean
DoesthepatienthaveevidenceofapriorMIorcardiacischemia?
Item
Does the patient have evidence of a prior MI or cardiac ischemia?
boolean
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial